| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (Cortex KO) / (Cortex WT) | Abundance Ratio (log2): (Cortex KO) / (Cortex WT) | Abundance Ratio P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Adj. P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Variability [%]: (Cortex KO) / (Cortex WT) | Abundances (Grouped): Cortex KO | Abundances (Grouped): Cortex WT | Abundances (Grouped) CV [%]: Cortex KO | Abundances (Grouped) CV [%]: Cortex WT | Abundances (Scaled): F1: 129, Sample, Cortex KO, 1 | Abundances (Scaled): F1: 130, Sample, Cortex KO, 2 | Abundances (Scaled): F1: 131, Sample, Cortex KO, 3 | Abundances (Scaled): F1: 126, Sample, Cortex WT, 1 | Abundances (Scaled): F1: 127, Sample, Cortex WT, 2 | Abundances (Scaled): F1: 128, Sample, Cortex WT, 3 | Abundances (Normalized): F1: 129, Sample, Cortex KO, 1 | Abundances (Normalized): F1: 130, Sample, Cortex KO, 2 | Abundances (Normalized): F1: 131, Sample, Cortex KO, 3 | Abundances (Normalized): F1: 126, Sample, Cortex WT, 1 | Abundances (Normalized): F1: 127, Sample, Cortex WT, 2 | Abundances (Normalized): F1: 128, Sample, Cortex WT, 3 | Abundance: F1: 129, Sample, Cortex KO, 1 | Abundance: F1: 130, Sample, Cortex KO, 2 | Abundance: F1: 131, Sample, Cortex KO, 3 | Abundance: F1: 126, Sample, Cortex WT, 1 | Abundance: F1: 127, Sample, Cortex WT, 2 | Abundance: F1: 128, Sample, Cortex WT, 3 | Abundances Count: F1: 129, Sample, Cortex KO, 1 | Abundances Count: F1: 130, Sample, Cortex KO, 2 | Abundances Count: F1: 131, Sample, Cortex KO, 3 | Abundances Count: F1: 126, Sample, Cortex WT, 1 | Abundances Count: F1: 127, Sample, Cortex WT, 2 | Abundances Count: F1: 128, Sample, Cortex WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P19096 | Fatty acid synthase OS=Mus musculus OX=10090 GN=Fasn PE=1 SV=2 | 0 | 235.187 | 31 | 54 | 70 | 54 | 2504 | 272.3 | 6.58 | 0.859 | -0.22 | 0.036188942 | 0.433736417 | 5.99 | 92.4 | 107.6 | 14.75 | 18.41 | 97.7 | 102.1 | 76.7 | 113.8 | 124 | 85.7 | 5000.1 | 5226.1 | 3924.2 | 5823.7 | 6348.2 | 4386.1 | 4688.8 | 4716.9 | 3918.5 | 5213.5 | 5524.2 | 4386.1 | 51 | 51 | 51 | 51 | 51 | 51 | cell differentiation;metabolic process;response to stimulus | cytoplasm;cytosol;Golgi;membrane;mitochondrion | catalytic activity;nucleotide binding;protein binding;RNA binding | "Pf00106, Pf00107, Pf00109, Pf00550, Pf00698, Pf00975, Pf02801, Pf08241, Pf08242, Pf08659, Pf12847, Pf13489, Pf13602, Pf13847, Pf14765" | 14104 | Fasn | 11 | ChREBP activates metabolic gene expression; Fatty acyl-CoA biosynthesis; Vitamin B5 (pantothenate) metabolism | ENSMUSG00000025153.9 | Fatty acid metabolism; Insulin signaling pathway; Metabolic pathways; AMPK signaling pathway; Fatty acid biosynthesis | Fatty Acid Biosynthesis; Dysregulated miRNA Targeting in Insulin/PI3K-AKT Signaling | 0 |